Republic Healthcare Limited (HK:8357)

:8357

8357

Republic Healthcare Limited

RESEARCH TOOLSreports

Want to see HK:8357 full AI Analyst Report?

Republic Healthcare Limited (8357) Price & Analysis

0 Followers

8357 Stock Chart & Stats

HK$0.12

HK$0.00(0.00%)

At close: Jan 03 4:00 PM EST

HK$0.12

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.07 - HK$0.24

Previous CloseN/A

Volume50.00K

Average Volume (3M)282.67K

Market Cap

HK$63.02M

Enterprise ValueHK$8.89M

Total Cash (Recent Filing)HK$9.75M

Total Debt (Recent Filing)HK$1.25M

Price to Earnings (P/E)―

Beta0.33

Next Earnings

Jul 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding624,000,000

10 Day Avg. Volume457,500

30 Day Avg. Volume282,666

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)1.51

Price to Sales (P/S)1.84

P/FCF Ratio-4.63

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Balance-sheet Equity CushionA sizable equity base and a history of conservative leverage (pre-2025) provide a durable solvency buffer that can absorb continued operating losses or permit measured refinancing. This improves the company’s ability to withstand stress and maintain operations over the next several months.

Defensive Industry ExposureOperating in the medical/care facilities sector implies structurally steady demand versus cyclical industries. Over a 2–6 month horizon, such exposure supports more stable occupancy and service needs, making revenue downside less sensitive to broad economic cycles than consumer cyclical peers.

Low Market Sensitivity (beta)A low beta indicates the company’s equity has historically moved less with market swings, reflecting either stable cash flows or idiosyncratic drivers. This relative stability can help preserve financing optionality and planning clarity through near-term volatility and supports more predictable operational execution.

Bears Say

Deteriorating ProfitabilitySustained gross and operating losses coupled with multi-year revenue declines signal weakening demand or pricing power and erode margins. Over months this reduces reinvestment capacity, increases reliance on external funding, and lowers visibility for returning to sustainable profitability.

Negative And Volatile Cash FlowRecent conversion to negative operating and free cash flow highlights fragile cash generation and recurring working-capital or operational strain. This undermines liquidity, forces dependence on financing, and raises the risk of constrained capital for maintenance, growth, or debt servicing over the coming months.

Rising Leverage In 2025A marked increase in debt coupled with deeper losses materially elevates solvency and refinancing risk. Higher leverage shortens the runway during loss-making periods and can pressure covenants or raise funding costs, impairing strategic flexibility and increasing default risk in a multi-month stress scenario.

8357 FAQ

What was Republic Healthcare Limited’s price range in the past 12 months?

Republic Healthcare Limited lowest stock price was HK$0.07 and its highest was HK$0.24 in the past 12 months.

What is Republic Healthcare Limited’s market cap?

Republic Healthcare Limited’s market cap is HK$63.02M.

When is Republic Healthcare Limited’s upcoming earnings report date?

Republic Healthcare Limited’s upcoming earnings report date is Jul 31, 2026 which is in 61 days.

How were Republic Healthcare Limited’s earnings last quarter?

Republic Healthcare Limited released its earnings results on Mar 26, 2026. The company reported -HK$0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.017.

Is Republic Healthcare Limited overvalued?

According to Wall Street analysts Republic Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Republic Healthcare Limited pay dividends?

Republic Healthcare Limited does not currently pay dividends.

What is Republic Healthcare Limited’s EPS estimate?

Republic Healthcare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Republic Healthcare Limited have?

Republic Healthcare Limited has 624,000,000 shares outstanding.

What happened to Republic Healthcare Limited’s price movement after its last earnings report?

Republic Healthcare Limited reported an EPS of -HK$0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.759%.

Which hedge fund is a major shareholder of Republic Healthcare Limited?

Currently, no hedge funds are holding shares in HK:8357

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Republic Healthcare Limited

Republic Healthcare Limited, a primary healthcare services company, provides consultation, medical investigation, and treatment services in Singapore. The company offers various treatment solutions for common medical conditions and focuses on sexual health and infectious diseases. It also provides treatment solutions for common skin conditions and basic medical aesthetics services. The company operates nine clinics under the Dr. Tan & Partners brand name; and one clinic under the S Aesthetics brand name. Republic Healthcare Limited was founded in 2010 and is headquartered in Singapore.